Psychedelic medicine is approaching a turning point. The U.S. needs the right infrastructure to be ready

Today’s psychedelics bear little resemblance to 1970s counterparts. These medicines undergo rigorous clinical trials and licensed manufacturing processes.

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (fortune.com)